Why Is Quantum-Si (QSI) Stock Down -4.05% Today?
Key Takeaways
- QSI shares were down roughly 4.05% intraday, trading near $1.17 versus a prior-session close of $1.22.
- The decline reflects profit-taking and consolidation after a sharp, speculation-driven rally on interim data for the company's next-generation Proteus protein-sequencing platform.
- A recent analyst downgrade to "Sell" and overbought technical conditions (RSI near 86) have added selling pressure.
- Fundamental concerns persist: minimal revenue, ongoing losses, and a "transition year" with roughly $1.0 million in projected 2026 revenue.
- Traders are watching upcoming third-quarter results and any further updates on the Proteus commercialization timeline.
Opening Summary
Quantum-Si Incorporated (QSI), a life sciences technology company developing single-molecule protein sequencing tools for proteomics research, was trading lower in Tuesday's session. The stock was down about 4.05% to roughly $1.17, compared with a prior close of $1.22. The move extends a multi-day pullback that began after the shares spiked on interim data from the company's Proteus platform, with markets citing profit-taking, an overbought technical setup, and lingering skepticism about near-term commercialization as the primary drivers.
Profit-Taking After a Speculative Run-Up
The dominant force behind the pullback appears to be investors locking in gains following an extraordinary short-term rally. Late in September, QSI shares surged after the company presented interim data at the World HUPO 2026 congress showing its Proteus platform generated roughly 30 times more peptide alignments than its current Platinum Pro system, with a substantially lower false-discovery rate. The stock climbed from below $1.00 to an intraday high above $1.55 within days, a move of more than 80% at its peak.
Such rapid, data-driven rallies in speculative, thinly commercialized life sciences names frequently attract momentum traders who exit once the initial catalyst cools. With no incremental news to sustain the advance, the stock has been unwinding those gains, falling in consecutive sessions from its early-October peak.
Analyst Downgrade and Fundamental Skepticism
The retreat has been compounded by a more cautious view from the sell side. Wall Street Zen downgraded QSI from "Hold" to "Sell" shortly after the surge, and commentary around the name has emphasized that the Proteus results are interim, company-reported, and not yet independently validated.
Underlying fundamentals remain challenging. The company is treating 2026 as a "transition year," guiding to revenue of approximately $1.0 million while it pivots toward the Proteus launch, which is not expected until 2027. Second-quarter revenue was minimal, and the company continues to post substantial net losses. Analysts and investors have noted that customers may be deferring purchases of the current Platinum instruments while awaiting Proteus, further pressuring near-term sales.
Market Context and Trading Activity
Trading volume has remained elevated relative to the stock's longer-term average, though it has eased from the extreme levels seen during the initial data-driven spike. The pullback has occurred as the shares pulled back from severely overbought technical conditions, with the relative strength index having reached levels above 85 during the rally. The stock has also traded around levels that carry listing-compliance significance: QSI received a Nasdaq notice earlier in 2026 after its share price fell below $1.00 for 30 consecutive business days, and the company has been working to sustain a bid above that threshold.
What Comes Next for QSI
Investors will be watching for the company's third-quarter results, as well as any additional performance milestones or validation data tied to the Proteus platform ahead of its targeted 2027 commercial launch. Management has emphasized a cash runway extending into 2028, but the investment case remains heavily dependent on execution and independent confirmation of the Proteus technology. Risks include potential launch delays, continued minimal revenue, ongoing cash burn, the possibility of future capital raises, and the stock's history of trading below the $1.00 listing threshold.
Trending AI Robots
For traders seeking a more systematic approach to volatile names like QSI, Tickeron's Trending AI Robots page offers a curated view of its top-performing AI trading bots. Tickeron provides hundreds of AI-driven trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and the symbols they trade. Explore the Trending AI Robots page to discover tools that may complement your own research process.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
QSI's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for QSI turned positive on September 17, 2026. Looking at past instances where QSI's MACD turned positive, the stock continued to rise in 38 of 43 cases over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on QSI as a result. In 79 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
QSI moved above its 50-day moving average on September 24, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for QSI crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +44.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where QSI advanced for three days, in 156 of 197 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 98 of 118 cases where QSI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.
Bearish Trend Analysis
The 10-day RSI Indicator for QSI moved out of overbought territory on October 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 26 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
QSI broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. QSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.966) is normal, around the industry mean (10.853). P/E Ratio (4.600) is within average values for comparable stocks, (98.910). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (100.000) is also within normal values, averaging (39.828).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry MedicalNursingServices
Advertisement